Citizens analyst Jonathan Wolleben lowered the price target on Structure Therapeutics (NASDAQ: GPCR) to $110.00 (from $113.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE